Please login to the form below

Not currently logged in
Email:
Password:

Celerion appoints chief medical officer

Dr Marc Hoffman brings experience from Patient IP and Theorem Clinical Research

Celerion Dr Marc HoffmanClinical research and pharmacology service provider Celerion has appointed Dr Marc Hoffman as chief medical officer.

Dr Hoffman joins Celerion from Patient Identification Platform, where he also served as chief medical officer, overseeing the firm's platform and programmes.

He brings further experience from Theorem Clinical Research, where he was chief medical officer, senior vice president and general manager.

Previously, Dr Hoffman served as vice president of medical and scientific affairs at Covance and vice president of global medical affairs and product safety at Hospira.

He also brings experience as vice president for global regulatory affairs and medical vigilance for Baxter's operations in Asia and the Americas.

Dr Susan Thornton, president and chief executive officer of Celerion, said: “We are pleased to have Marc join our executive leadership team during this exciting period of growth in our company.

“His depth of experience in managing all aspects of global drug development in multiple therapeutic areas will not only make him a valuable asset for our organization but also for our clients.”

27th February 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics